CURE’s thyroid cancer page is an extensive resource of cancer information featuring the latest thyroid cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on thyroid cancer.
April 21st 2022, 1:00pm
Health care specialists share insight on the work-up of patients with iodine-refractory differentiated thyroid cancer and how this may affect systemic therapy options.
April 15th 2022, 3:00pm
From a Netflix star revealing a breast cancer diagnosis to “Good Morning America” host Robin Roberts sharing what emotions she felt when partner Amber Laign was diagnosed with breast cancer, here’s what is happening in the cancer space this week.
April 14th 2022, 1:15pm
Discussion on when differentiated thyroid cancer is determined to be iodine-refractory, and how patients should be followed in this setting.
April 14th 2022, 1:00pm
Expert perspectives on the process of surgery and radiation therapy used for less severe cases of differentiated thyroid cancer.
April 7th 2022, 1:15pm
Jim Lesniak shares his experience of receiving a diagnosis of and being treated for differentiated thyroid cancer.
April 7th 2022, 1:00pm
Considerations for the role of patient advocacy groups and patient-to-patient education in the differentiated thyroid cancer journey.
April 5th 2022, 7:00pm
Monumental treatment advancements over the past two decades have given patients with thyroid cancer the ability to live longer and better lives, according to an expert from Cleveland Clinic’s Taussig Cancer Institute. However, more work is needed to find curative treatments.
March 31st 2022, 1:20pm
Expert perspectives on the broad management of differentiated thyroid cancer, including surgery, radiation treatment, and systemic therapy.
March 31st 2022, 1:00pm
Health care specialists provide an overview on the nature of differentiated thyroid cancer and discuss subtypes of disease that patients may present with.
March 22nd 2022, 7:00pm
Although certain cancer treatments have been linked to an increased risk of a secondary cancer years later, an expert notes there are no genetic or pathologic studies that prove the association between new and previous cancers.
How to Access Support Resources for Rare Cancers
The Defining Moments of Support After Hearing ‘You Have Cancer’
Off-the-Shelf Immunotherapy May Offer Benefits in Kidney Cancer
Gleevec Associated With Long-Term Effectiveness in Treating GIST